Biomimetic Platelet Nanomotors for Site-Specific Thrombolysis and Ischemic Injury Alleviation

Yan-Ting Chen,Chia-Hung Liu,Wen-Yu Pan,Pei-Ru Jheng,Yves S. Y. Hsieh,Thierry Burnouf,Yu-Jui Fan,Chia-Che Chiang,Tzu-Yin Chen,Er-Yuan Chuang

DOI: https://doi.org/10.1021/acsami.3c06378

IF: 9.5

2023-06-30

ACS Applied Materials & Interfaces

Abstract:Due to the mortality associated with thrombosis and its high recurrence rate, there is a need to investigate antithrombotic approaches. Noninvasive site-specific thrombolysis is a current approach being used; however, its usage is characterized by the following limitations: low targeting efficiency, poor ability to penetrate clots, rapid half-life, lack of vascular restoration mechanisms, and risk of thrombus recurrence that is comparable to that of traditional pharmacological thrombolysis...

materials science, multidisciplinary,nanoscience & nanotechnology

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are thrombosis and the mortality rate caused by its high recurrence rate. Specifically, the paper focuses on the application of non - invasive site - specific thrombolytic methods in the treatment of thrombotic diseases. However, the existing non - invasive site - specific thrombolytic methods have the following limitations:

1. **Low targeting efficiency**: It is difficult for drugs to reach the thrombus site accurately.
2. **Poor penetration ability**: It is difficult for drugs to penetrate deep into the thrombus.
3. **Short half - life**: The effective time of drugs in the body is relatively short.
4. **Lack of vascular recovery mechanism**: Drugs cannot effectively promote the repair of damaged blood vessels.
5. **High risk of thrombus recurrence**: Compared with traditional pharmacological thrombolytic agents, the risk of thrombus recurrence is similar.

To overcome these limitations, the research team has developed a cotton - ball - like platelet (PLT) biomimetic self - assembly framework, which combines the photothermal treatment polymer poly(3,4 - ethylenedioxythiophene) (PEDOT) platform. This platform can deliver the synthetic peptide P6 derived from hirudin to the thrombus lesion site, forming P6@PEDOT@PLT nanomotors, achieving non - invasive site - specific thrombolysis, effective anticoagulation and vascular repair.

### Main innovation points

1. **Targeted delivery**: Mediated by P - selectin, P6@PEDOT@PLT nanomotors can accurately target the thrombus site.
2. **Photothermal response**: Under near - infrared (NIR) irradiation, the nanomotors can rupture, achieving ideal sequential drug release.
3. **Motility**: Under NIR irradiation, P6@PEDOT@PLT nanomotors have good motility, can effectively penetrate the thrombus lesion site and improve bioavailability.
4. **Photothermal/photoelectric combined therapy**: The combination of photothermal therapy and photoelectric therapy significantly enhances the thrombolytic effect (about 72%).
5. **Multiple biological effects**: The precisely delivered drugs and the resulting photothermal - driven heat shock proteins, immunomodulation, anti - inflammation and plasminogen activator inhibitor - 1 (PAI - 1) inhibitory activities can repair blood vessels and effectively prevent re - thrombosis.

### Experimental verification

The paper verifies the effectiveness and safety of P6@PEDOT@PLT nanomotors through a variety of experimental methods, including in vitro cytotoxicity testing, platelet binding affinity testing, antithrombotic (clot inhibition) effect evaluation, in vitro clot lysis testing, in vivo thrombus model construction, thrombolysis and prevention effect evaluation, blood flow velocity measurement and biological effect evaluation, etc.

In conclusion, this research proposes a new non - invasive site - specific thrombolytic method, which is expected to improve the treatment effect of thrombosis - related diseases.